Peipei Wang

10PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 18, 2026
Platelet-to-lymphocyte ratio and systemic inflammation response index are the optimal combination for risk stratification in patients with nasopharyngeal carcinoma.

|Nov 29, 2024
A dendritic cell vaccine for both vaccination and neoantigen-reactive T cell preparation for cancer immunotherapy in mice.

Qing Li, Hao Zeng, Ting Liu

|Sep 20, 2024
NRI and SIRI are the optimal combinations for prognostic risk stratification in patients with non-small cell lung cancer after EGFR-TKI therapy.

Xia Liu, Peipei Wang, Guolong Liu

|Apr 18, 2023
Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia.

Peipei Wang, Yuling Zhang, Qinghua Cai

|Mar 24, 2022
Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer.

Ye Hong, Ping Duan, Lang He

|Feb 25, 2022
Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer.

Yue Zheng, Yang Fu, Pei-Pei Wang

Pageof 2

Frequent Collaborators

5 joint publications

Zhenyu Ding

2 joint publications

Ting Liu

2 joint publications

Yue Zheng

1 joint publications

Yang Fu